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Exposure to early life physiological stressors, such as infection, is thought to contribute
to the onset of psychopathology in adulthood. In animal models, injections of the
bacterial immune challenge, lipopolysaccharide (LPS), during the neonatal period has
been shown to alter both neuroendocrine function and behavioral pain responses in
adulthood. Interestingly, recent evidence suggests a role for the lateral hypothalamic
peptide orexin in stress and nociceptive processing. However, whether neonatal LPS
exposure affects the reactivity of the orexin system to formalin-induced inflammatory
pain in later life remains to be determined. Male Wistar rats (n = 13) were exposed
to either LPS or saline (0.05mg/kg, i.p) on postnatal days (PND) 3 and 5. On PND
80–97, all rats were exposed to a subcutaneous hindpaw injection of 2.25% formalin.
Following behavioral testing, animals were perfused and brains processed for Fos-protein
and orexin immunohistochemistry. Rats treated with LPS during the neonatal period
exhibited decreased licking behaviors during the interphase of the formalin test, the period
typically associated with the active inhibition of pain, and increased grooming responses
to formalin in adulthood. Interestingly, these behavioral changes were accompanied
by an increase in the percentage of Fos-positive orexin cells in the dorsomedial and
perifornical hypothalamus in LPS-exposed animals. Similar increases in Fos-protein were
also observed in stress and pain sensitive brain regions that receive orexinergic inputs.
These findings highlight a potential role for orexin in the behavioral responses to pain and
provide further evidence that early life stress can prime the circuitry responsible for these
responses in adulthood.
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INTRODUCTION
Chronic pain is a debilitating condition for which effective treat-
ments and the underlying neurobiological mechanisms respon-
sible are yet to be fully identified (Dersh et al., 2002). Pain
characteristically evokes emotional responses in individual suffer-
ers and is often comorbid with negative affective states including
anxiety and depression and sleep disturbances (Neugebauer et al.,
2004; Katon et al., 2007). Interestingly, the normal maturation of
the nociceptive system is dependent on the uninterrupted devel-
opment of sensory inputs in early life (Fitzgerald, 2005). Exposure
to adverse events during this sensitive period of development,
when the nociceptive circuitry is undergoing fine-tuning, can pre-
cipitate maladaptive pain processing in later life. For example, in
humans, early life physical stressors have been associated with an
increased risk for developing chronic pain conditions in adult-
hood (Davis et al., 2005). Similarly, recent preclinical research
conducted by our group has indicated that early life exposure
to the immune challenge lipopolysaccharide (LPS) resulted in
hyperalgesia in response to formalin, a model of inflammatory
pain, in young rats (Zouikr et al., 2014b). Despite recent efforts,
the neural circuitry modulating the increased response to pain
following early life stress remains to be fully determined.
Importantly, the hypothalamus controls neuroendocrine stress
responses and nociceptive processing (Hsieh et al., 1996;
Matthews, 2002). Direct afferent and efferent relays connect
hypothalamic nuclei to brain areas involved in the active mod-
ulation of pain and nociception such as the dorsal horn of
the spinal cord and the periaqueductal gray (PAG; Holland and
Goadsby, 2007; Todd, 2010). Additionally, subregions such as the
perifornical and lateral hypothalamic areas are key brain struc-
tures coordinating behavioral and autonomic stress responses and
receive significant corticolimbic input (Millan, 2002). Recently,
a subpopulation of hypothalamic neurons which produce the
neuropeptides orexins (hypocretins), have been identified as pos-
sible substrates in the modulation of pain and stress through
projections to the PAG, brainstem and paraventricular thalamus
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(PVT; Peyron et al., 1998; Marcus et al., 2001). For example,
injections of orexin-A into the rostral ventromedial medulla pro-
duced antinociceptive-like behavior in response to formalin in
male rats (Azhdari-Zarmehri et al., 2014). Interestingly, maternal
separation was found to alter orexin system reactivity to psy-
chological stress in adulthood (James et al., 2014). Despite these
results, only a few studies have assessed orexin system recruitment
and also studied behavioral responses following noxious stimuli.
Watanabe et al. (2005) demonstrated that prepro-orexin knock-
out mice exhibited increased nociceptive behaviors in response
to peripheral inflammation and reduced stress-induced analgesia
following footshock stress in adulthood compared to wild type
mice. Further, Heidari-Oranjaghi et al. (2012) found that intrac-
erebroventricular (i.c.v) injections of the OX1 orexin receptor
antagonist SB-334867, resulted in increased pain responses to for-
malin, but only following both restraint and swim stress. Recently,
we demonstrated that rats exposed to neonatal LPS displayed
enhanced formalin-induced flinching but not licking responses
in adolescence at postnatal day (PND) 22 (Zouikr et al., 2014b).
These behavioral changes were accompanied by attenuated Fos-
protein cell counts in the rostral dorsal PAG as well as the rostral
and caudal axes of the ventrolateral PAG. But, whether exposure
to early life immune challenge alters orexin system function in
response to a noxious stimulus in adulthood (PND 80–97) has
not been determined. This information will improve our under-
standing as to how neonatal physical and emotional insults can
rewire the brain pathways involved in pain and stress processing.
Therefore, the aim of the present study was to assess the effect
of neonatal LPS exposure on the reactivity of the orexin system,
as assessed by Fos-protein expression, to formalin challenge in
adulthood (PND 80–97). Given the relationship between stress,
nociception and the orexin system, it was hypothesized that rats
exposed to LPS in early life would demonstrate increased pain
and grooming responses to formalin in adulthood. We predicted
that these behavioral responses would be accompanied by evi-
dence of increased orexin cell activity, and that this recruitment
pattern would also be reflected in Fos-responses in downstream
projection targets of this system.
METHODS AND MATERIALS
ETHICS STATEMENT
All experiments performed were approved by the University of
Newcastle Animal Care and Ethics Committee, and carried out
in accordance with the National Health and Medical Research
Council Australian Code of Practice for the care and use of
animals for scientific practice.
ANIMALS
Four experimentally naïve female Wistar rats were obtained from
the University of Newcastle Animal house and bred with two
experimentally naïve males in the University of Newcastle vivar-
ium. On PND 3 and 5 a random subset of animals from each litter
were administered LPS as a neonatal immune challenge (detailed
below). A total of 13 male offspring were included in this study,
6 LPS-exposed animals and 7 saline animals. On PND 21, ani-
mals were weaned with 2 animals/cage (41.5 ×28 × 22 cm cages;
Mascot Wire Works, Sydney). Food (Rat and Mouse Pellets, Glen
Forest, Western Australia) and water were available ad libitum and
rats were maintained on a 12 h light (0600–1800): 12 h dark cycle.
Temperature was maintained at 20 ± 2◦C and humidity was kept
at 34 ± 2%.
NEONATAL LPS CHALLENGE
The neonatal LPS procedure was performed as per previously
published procedures (Walker et al., 2009). Between 0900 and
1000 h on PND 3 and 5 (birth as PND 1), pups in the LPS treat-
ment condition were briefly removed from their home cages and
administered 0.05mg/kg LPS (intraperitoneally, i.p, LPS from
Salmonella enterica, serotype enteritidis, Sigma-Aldrich, USA, dis-
solved in 20µl sterile pyrogen-free saline). Saline controls were
given an equal volume of sterile saline (Livingstone International,
Australia). The timing of injection and dose were selected as it had
been previously shown to produce a sustained immune response
with no mortality (Walker et al., 2006).
FORMALIN TEST
This test has been previously described in our laboratory (Zouikr
et al., 2014c) and is a well-validatedmodel of behavioral responses
to nociceptive stimuli (early phase or phase 1, first 5min),
inhibition of nociceptive responding (interphase, 5–15min) and
inflammation (late phase or phase 2, 15–60min; Wheeler-Aceto
and Cowan, 1991; Tjølsen et al., 1992; Henry et al., 1999; Fischer
et al., 2014). Between PND 80 and 97 animals were removed
from their home cage and a subcutaneous injection of formalin
(2.25%) was administered into the plantar surface of the right
hindpaw of all rats (50µl formaldehyde 36.5–38%; Biolab Ltd,
Victoria, Australia; sodium chloride injection BP 0.9% Pfizer,
Australia). This volume and concentration of solution has been
previously shown by our group to produce the biphasic response
of the formalin test (Zouikr et al., 2013). A saline control injec-
tion into the hindpaw was not included, as this has been found to
produce no pain-induced behaviors including licking and flinch-
ing (Guy and Abbott, 1992; Butkevich and Vershinina, 2001).
The behavioral response to formalin was examined in transpar-
ent plexiglas boxes (30 × 30 × 30 cm) for 1 h. A researcher blind
to experimental conditions scored behavioral responses using
JWatcher ethograph software (version 0.9, Macquarie University,
Sydney, Australia). Pain behaviors were measured by the num-
ber of flinches of the injected paw and the time spent licking
the injected paw. Exploratory behavior was measured as the time
spent rearing during the formalin test and grooming behavior
during the formalin test was analyzed as the time spent grooming
the forepaws.
IMMUNOHISTOCHEMISTRY
Ninety minutes following formalin injections, rats were deeply
anaesthetized with an overdose of sodium pentobarbitone
(200mg/kg; i.p; Virbac, Australia) and transcardially perfused
with 200mL of 0.1M phosphate buffered saline followed by
500mL of 4% paraformaldehyde (pH 9.5). Brains were then
removed and postfixed in 4% paraformaldehyde (24 h at 4◦C)
and then stored in 15% sucrose until sectioning. Serial coro-
nal sections of the rostral forebrain (40-µm) and caudal mid-
brain (50-µm) were cut using a freezing microtome (Leica
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Microsystems, SM2000R). A 1-in-4 series of sections from the
hypothalamus (bregma−2.28 to−3.24), the PVT (bregma−2.28
to −3.24), the paraventricular nucleus of the hypothalamus
(PVN; bregma −1.46 to −1.78) and the amygdala (bregma −2.28
to −3.08), and a 1-in-5 series of sections from the PAG (bregma
−6.69 to −8.19) were processed for immunohistochemical detec-
tion of Fos-protein (72 h, 1:10000, rabbit polyclonal, sc-52, Santa
Cruz Biotechnology, CA, USA) as described previously in detail
(Dayas et al., 2008; James et al., 2014). Following primary anti-
body application, sections were incubated in a secondary anti-
body (2 h, 1:300, donkey anti rabbit, 711-065-152, Jackson IR,
PA, USA). Hypothalamic sections were dual-labeled for orexin-A,
also likely detecting pre-pro orexin (48 h, 1:15000, orexin-A anti-
body, goat polyclonal, sc-8070, Santa Cruz Biotechnology). The
selectivity of this antibody has been illustrated in a recent study
by Blanco-Centurion et al. (2013). Please see Supplementary
Material S1 outlining the details of the specificity of the orexin-A
antibody. Following orexin primary antibody application, sec-
tions were subsequently incubated in a secondary antibody (2 h,
1:400, donkey anti goat, 705-065-147, Jackson IR, PA, USA).
An equal number of animals from each treatment group were
included in each individual immunohistochemical run.
Bilateral counts of single-labeled Fos-positive cells were made
in the PVT, PVN, basolateral amygdala (BLA), medial nucleus of
the amygdala (MeA), the central nucleus of the amygdala includ-
ing both lateral and medial subdivisions (CeL, CeM respectively),
the dorsal PAG (including both the dorsomedial and dorso-
lateral columns), and the lateral and ventrolateral PAG using
Metamorph Imaging System Software (Version 7.5; Molecular
Devices Analytical Technologies) at 10x magnification (Olympus
CX40). Quantification of Fos-positive cells was determined by
creating a region of interest for each brain structure and a
thresholding procedure was used to quantify Fos expression.
Counts of Fos-positive orexin cells were made in the dorsome-
dial hypothalamus (DMH), the perifornical area (PFA), and the
lateral hypothalamus (LH) by one observer, blind to treatment,
using a 20x microscopic objective (Olympus CX40). The DMH
was defined as the area between the third ventricle and the medial
side of the PFA, the PFA was defined as the area surrounding the
fornix and the LH was defined as the area from the lateral side of
the PFA to the optic tract (Laorden et al., 2012; James et al., 2014).
All brain coordinates were adapted from the Paxinos and Watson
atlas (Paxinos and Watson, 2007).
DATA ANALYSIS
Initial analysis of covariance (ANCOVA) analyses revealed no
significant effect of litter size on both behavioral and brain com-
parisons. Behavioral data was analyzed across neonatal treatment
group using one-way between subjects ANOVAs for each phase
of the formalin test. Using area under the curve calculations for
the formalin test, phase 1 was considered the first 5min, the
interphase was the sum of 6–15min, and phase 2 was the sum
of responses from 16–60min. Fos-protein immunohistochemical
data was analyzed using two-way between subjects ANOVAs com-
paring neonatal treatment and brain region where appropriate,
alternatively one-way ANOVAs were used. Post-hoc comparisons
were assessed using least significant differences tests. Pearson’s
correlations were used to examine the relationship between the
percentage of Fos-positive orexin cells in the subregions of the
hypothalamus and behavioral responses of animals in phase 1 and
the interphase of the formalin test. All statistical analyses were
conducted using IBM SPSS V21 with an alpha value of 0.05. All
figures are represented as means with standard errors.
RESULTS
EFFECT OF NEONATAL LPS EXPOSURE ON FORMALIN-INDUCED
NOCICEPTIVE BEHAVIOR
One-way between subjects ANOVAs revealed no significant effect
of neonatal treatment on flinching behavior in any phase of the
formalin test (p’s > 0.05; Figures 1A,B). An analysis of licking
responses revealed a significant effect of neonatal treatment dur-
ing the interphase with LPS animals displaying reduced time
spent licking compared to saline controls [F(1, 12) = 3.795, p =
0.042; Figures 1C,D].
EFFECT OF LPS ON FORMALIN-INDUCED EXPLORATORY AND
GROOMING BEHAVIORS
One-way between subjects ANOVAs revealed a significant effect
of neonatal treatment on the total time spent grooming in the
interphase of the formalin test with LPS-treated animals spending
more time grooming compared to saline animals [F(1, 12) = 6.96,
p = 0.014; Figures 2A,B]. LPS-treated animals also displayed sig-
nificantly increased time grooming from phase 1 to the interphase
of the formalin test compared to saline animals [F(1, 12) = 5.538,
p = 0.022; Figure 2B]. ANOVA also revealed no significant effects
of neonatal treatment on time spent grooming during phase 1 or
phase 2, nor for time spent rearing in any phase of the formalin
test (p’s> 0.05; Figures 2C,D).
EFFECT OF NEONATAL IMMUNE CHALLENGE ON OREXIN CELL
REACTIVITY IN RESPONSE TO FORMALIN IN ADULTHOOD
There were no differences found in the total number of orexin-
positive cells between LPS animals and saline controls in any
subregion of the hypothalamus (p’s > 0.05, Table 1). However,
a two-way between subjects ANOVA revealed a significant main
effect of neonatal treatment on the percentage of Fos-positive
orexin cells with LPS-exposed rats exhibiting a greater per-
centage of Fos-positive orexin cells compared to saline-treated
animals [F(1, 246) = 11.863, p = 0.001, Figure 3]. Additionally,
there was a significant interaction between neonatal treatment
and hypothalamic subregion on the percentage of Fos-positive
orexin cells [F(2, 246) = 3.387, p = 0.035]. Post-hoc comparisons
revealed that LPS animals displayed significantly greater percent-
ages of Fos-positive orexin cells in the DMH and PFA compared
to saline controls (p’s< 0.05) however, no differences were found
in the LH (p > 0.05, Figure 3).
EFFECT OF LPS ON FOS-PROTEIN EXPRESSION IN THE PVT, PVN,
AMYGDALA AND PAG
A one-way between subjects ANOVA revealed that LPS-treated
animals exhibited significantly greater numbers of Fos-positive
cells in the PVT and PVN compared to saline controls [F(1, 82) =
59.055, p<0.001; F(1, 31) = 9.370, p = 0.005; Figures 4A,B].
A two-way between subjects ANOVA revealed a significant
interaction of neonatal treatment and amygdala subregion on the
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FIGURE 1 | Neonatal LPS exposure enhanced pain suppression of licking
behaviors during the interphase in response to formalin in adulthood.
Time course of flinching and licking responses for LPS and saline rats
exposed to formalin in adulthood (A,C). No differences were observed in
flinching behavior across any phase of the formalin test between LPS-treated
rats and saline controls (B). LPS-exposed rats exhibited a potentiated
inhibitory pain response to formalin in licking behaviors during the interphase,
with no effect of neonatal treatment on phase 1 or phase 2 of the formalin
test (D). Data are presented as mean + standard error. ∗p < 0.05. SAL:
n = 7; LPS: n = 6.
number of Fos-positive cells [F(3, 280) = 2.896, p = 0.036]. Least
significant differences comparisons revealed that LPS-treated ani-
mals displayed a significantly greater number of Fos-positive cells
in the MeA compared to saline animals (p = 0.001; Figure 4C).
A two-way between subjects ANOVA revealed a main effect of
neonatal treatment on the number of Fos-positive cells within
the PAG [F(1, 204) = 38.440, p < 0.001]. Post-hoc comparisons
revealed that LPS-treated animals displayed significantly greater
numbers of Fos-positive cells in the dorsal (p = 0.022), lat-
eral (p < 0.001) and ventrolateral PAG (p < 0.001) compared to
saline animals (Figure 4D).
CORRELATIONS BETWEEN OREXIN CELL ACTIVITY AND BEHAVIORAL
RESPONSES TO FORMALIN IN ADULTHOOD
Correlation analyses revealed a negative correlation between the
total time spent licking in phase 1 of the formalin test and the
percentage of Fos-positive orexin cells in the DMH (r = −0.806,
p = 0.005) and the PFA (r = −0.691, p = 0.027; Figures 5A,B).
In the interphase of the formalin test, total time spent grooming
was also positively correlated with the percentage of Fos-positive
orexin cells in the DMH (r = 0.634, p = 0.049) and PFA (r =
0.673, p = 0.033, Figures 5C,D).
DISCUSSION
In the current study we show that animals exposed to LPS in early
life exhibit altered behavioral responses to a formalin challenge
in adulthood. LPS-treated animals displayed increased orexin cell
activity, as assessed by Fos-like immunoreactivity in the DMH
and PFA but not LH. Additionally, increases in numbers of Fos-
positive neurons were observed in stress and pain sensitive brain
regions that express orexin receptors including the PVT, PVN,
MeA, and PAG.
INCREASED OREXIN CELL REACTIVITY TO FORMALIN FOLLOWING AN
EARLY LIFE IMMUNE CHALLENGE
The primary aim of this study was to examine the response
of orexin neurons to an acute formalin injection in adulthood
following early life LPS exposure. Using Fos-protein immuno-
histochemistry, we observed an increase in the recruitment of
DMH and PFA orexin neurons in LPS-exposed rats compared
to controls. Interestingly, no change in orexin cell reactivity to
formalin was observed in the LH. This differential recruitment
pattern is interesting given the recent suggestions of a dichotomy
of function between medial and lateral orexin cell populations
(Estabrooke et al., 2001; Harris and Aston-Jones, 2006). For
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FIGURE 2 | An early life immune challenge increased self-grooming
responses to formalin in adulthood. Time course of grooming and rearing
responses for LPS and saline animals (A,C). LPS-treated rats displayed
increased grooming behaviors in response to formalin when compared to
saline animals (B). There was no effect of neonatal treatment on rearing
behavior across all phases of the formalin test (D). Data are presented as
mean + standard error. ∗p < 0.05, #p < 0.05 phase 1 vs. interphase. SAL:
n = 7; LPS: n = 6.
Table 1 | Orexin cell expression in each subregion of the
hypothalamus.
Treatment Region Orexin number Fos-Orexin number
Saline (n = 6) DMH 30.77±3.65 11.97±1.55
PFA 111.33±10.56 19.99±2.71
LH 35.18±2.33 3.35±0.41
LPS (n = 6) DMH 30.89±2.85 16.89±2.34
PFA 101.59±7.02 29.62±3.77
LH 39.60±3.13 4.72±0.63
Data presented as average number of orexin cells or Fos-positive orexin cells ±
standard error mean in the dorsomedial hypothalamus (DMH), perifornical area
(PFA), and lateral hypothalamus (LH).
example, orexin neurons in the DMH and PFA have been linked
with arousal and the modulation of the stress response whereas
those located in the LH have been linked with reward (Harris
et al., 2005). In support, rats administered sodium-lactate to
induce panic anxiety exhibited increased activation of DMH-PFA
but not LH orexin neurons (Johnson et al., 2010). Thus, arousal
and stress responsive orexin cells may be preferentially sensitized
by early life immune stress.
FIGURE 3 | LPS resulted in an increase in the percentage of
Fos-positive orexin cells in both the dorsomedial (DMH) and
perifornical (PFA) subregions of the hypothalamus. The percentage of
Fos-positive orexin cells in the DMH and PFA was significantly higher in
LPS-exposed animals compared to saline controls. No differences were
observed in orexin cell activity in the lateral hypothalamus (LH) across
neonatal treatment groups. Photomicrographs of coronal sections of the
hypothalamus immunolabeled for Fos-protein and orexin. Data are
presented as mean + standard error. ∗p < 0.05, ∗∗p < 0.01, scale bar
20µm. SAL: n = 6; LPS: n = 6.
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FIGURE 4 | Neonatal LPS treatment resulted in an increase in the
number of Fos-positive cells in the paraventricular thalamus (PVT),
paraventricular nucleus (PVN), the medial nucleus of the amygdala
(MeA) and the periaqueductal gray (PAG). Early life LPS treatment resulted
in an increase in Fos activity in both the PVT and PVN (A,B).
Photomicrographs of coronal sections of the PVT and PVN immunolabeled
for Fos-protein (A,B). LPS-treated animals also exhibited an increased
number of Fos-positive cells in the MeA (C). There was no effect of neonatal
treatment on any other subregion of the amygdala. LPS-exposed rats also
had increased Fos-protein expression in the dorsal, lateral and ventrolateral
PAG (D). Data are presented as mean + standard error. ∗p < 0.05, ∗∗p < 0.01,
∗∗∗p < 0.001, scale bar 100µm, 3V = third ventricle. SAL: n = 6; LPS: n = 6.
It is unclear from the present study which pain sensitive
afferent pathways may have been involved in the recruitment
of orexin neurons. Brain sites that receive direct afferent inputs
from lamina I projection neurons in the superficial dorsal horn
include the ventrolateral medulla, nucleus of the solitary tract,
lateral parabrachial nucleus, PAG and the thalamus (Millan,
2002; Gauriau and Bernard, 2004; Todd, 2010). The parabrachial
nucleus is interesting in this regard possessing efferent projections
to the amygdala and the LH (Bernard et al., 1993; Bester et al.,
1997; Gauriau and Bernard, 2002). These inputs may directly
recruit orexin neurons. Additionally, the spinal cord sends direct
projections to the hypothalamus. For example, Burstein et al.
(1987) demonstrated direct projections from three regions of
the spinal gray matter, including the lateral reticulated area, the
area surrounding the central canal and the marginal zone, to
the hypothalamus (Burstein et al., 1987; Giesler, 1995). However,
the direct input from these spinal cord regions to orexin neu-
rons is yet to be examined. Interestingly, the stress responsive
central nucleus of the amygdala (CeA) and MeA also project
to the LH (Peyron et al., 1998; Yoshida et al., 2006) and may
provide “top-down” afferent input to the LH. Clearly, further
work will be required to determine whether the activation of
orexin neurons occurs through ascending nociceptive pathways
or descending inputs from stress responsive centers such as the
amygdala. It is important to acknowledge that because previ-
ous work has shown that hindpaw saline injections cause no
pain-induced behaviors including licking and flinching (Guy
and Abbott, 1992; Butkevich and Vershinina, 2001), we did not
include a Fos control group for the formalin challenge. While it is
difficult to determine the direction of change from baseline in our
Fos-induced orexin cell reactivity, prior studies have shown that
rats subjected to hindpaw saline injections showed no Fos label-
ing in the lumbar spinal cord (Yi and Barr, 1995). Additionally,
Barr (2011) reported that 14 day old rat pups given saline
into their hindpaw did not exhibit Fos labeling in the PVN or
dorsal/lateral PAG.
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FIGURE 5 | Correlations of the percentage of Fos-positive orexin cellswith
licking and grooming behaviors during the formalin test. Significant
negative correlations were found between the time spent licking (secs) during
phase 1 of the formalin test and the percentage of Fos-positive cells in the
dorsomedial hypothalamus (DMH) and perifornical area (PFA; A,B). Significant
positivecorrelationswere foundbetween the timespentgrooming (secs)during
the interphase of the formalin test and the percentage of Fos-positive orexin
cells in the DMH and PFA (C,D). ∗p < 0.05, ∗∗p < 0.01. SAL: n = 6, LPS: n = 6.
ENHANCED FORMALIN-INDUCED INHIBITORY PAIN RESPONSE IN
LPS-TREATED RATS
The formalin test is a well-established animal model of persistent
pain (Tjølsen et al., 1992). Three distinct behavioral responses
are commonly associated with the formalin test. The early phase,
or phase 1, involves the direct chemical stimulation of nocicep-
tors, the interphase denotes the active inhibition of pain and the
late phase, or phase 2, represents the inflammatory pain response
(Dubuisson and Dennis, 1977; Tjølsen et al., 1992; Franklin and
Abbott, 1993; Henry et al., 1999; Fischer et al., 2014). Importantly,
of these three phases, the interphase has received the least atten-
tion. Here, we demonstrated decreased licking behaviors in the
interphase after formalin challenge in LPS animals. This is per-
haps not surprising given that increased grooming may override
or mask changes in licking behavior. Although a slight trend was
observed in phase 2 we found no significant changes in flinch-
ing behavior in response to formalin between treatment groups
in male rats. This is in contrast with our recently published work
whereby adult rats exposed to a neonatal LPS challenge displayed
a significantly increased flinching response during the late phase
of the formalin test (Zouikr et al., 2014a). This discrepancy could
be attributed to methodological differences, presently, we ana-
lyzed the interphase whereas Zouikr et al. (2014a) focused on
phase 2 of the formalin test. Further, differences in behavioral
scoring methods (manual vs. software) may have contributed to
this discrepancy. Lastly, enhanced grooming in the current cohort
may havemasked changes in flinching. The putative enhancement
of pain suppression observed in the interphase of LPS-treated
rats is interesting given the increase in orexin cell reactivity
in LPS-exposed rats. Furthermore, overall licking behaviors of
LPS-treated rats negatively correlated with the percentage of Fos-
positive orexin cells in the DMH and PFA. These findings are
consistent with data implicating the orexin system in descending
inhibitory pain pathway control (Bingham et al., 2001).
In the current study we also observed an increase in Fos-
protein in all subregions of the PAG in neonatally LPS-treated
rats compared to controls. It is important to note that the PAG is
anatomically organized into longitudinal columns including the
dorsal PAG, the lateral PAG and the ventrolateral PAG and each
column plays distinct roles in the response to both stress and pain
(Bandler and Shipley, 1994). The PAG has a well-characterized
role in analgesia and stress coping and is the recipient of orexin-
ergic innervation (Peyron et al., 1998; Keay and Bandler, 2002;
Gebhart, 2004; Chapman et al., 2008). It is possible that the
increase in orexin cell activity and the enhanced inhibitory pain
response to formalin contribute to the active inhibition of pain
through projections to the PAG. In support, Azhdari-Zarmehri
et al. (2011) found that microinjections of orexin-A into the
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PAG enhanced inhibitory pain responses in the interphase in
response to formalin in adulthood. Indeed, orexin-A has been
shown to reduce inhibitory postsynaptic currents in ventrolateral
PAG neurons that directly project to the rostral ventromedulla
(Ho et al., 2011). Of the PAG columns, the lateral PAG tends to
receive stronger orexin inputs, which is interesting given its role
in active coping strategies in the response to pain (Bandler and
Shipley, 1994; Yoshida et al., 2006). Accordingly, the pattern of
Fos activity we observed in the PAG may reflect affective cop-
ing strategies in response to formalin-evoked stress. For example,
Keay and Bandler (2001) demonstrated that increased Fos activ-
ity in both the ventrolateral and lateral PAG is linked with altered
emotional coping responses to persistent pain. These results may
help explain the affective behavioral changes observed in response
to formalin as described in more detail below.
EARLY LIFE LPS EVOKED AN AFFECTIVE-LIKE BEHAVIORAL RESPONSE
TO FORMALIN
We also examined the affective-like responses to formalin
in adulthood by assessing both grooming and rearing. Self-
grooming is thought to reflect a coping mechanism to produce
de-arousal (Spruijt et al., 1992; Kalueff and Tuohimaa, 2005;
Lariviere et al., 2011). In our study, LPS-exposed animals spent
significantly more time grooming in response to formalin in
adulthood compared to saline controls. No differences were
observed in rearing behavior. In keeping with our findings, Aloisi
et al. (1998) demonstrated that exposure to acute restraint stress
in adulthood increased self-grooming during the interphase of
the formalin test. Interestingly, our study found that an increase in
orexinergic activity was correlated with an increase in grooming
behavior following formalin injection. These data are in line with
previous research implicating dysregulated orexin system func-
tion in affective behavioral responses to stress or adverse expe-
riences in adulthood (Johnson et al., 2010; Li et al., 2010; James
et al., 2014; Yeoh et al., 2014). Further, Low and Fitzgerald (2012)
have demonstrated an increase in the number of Fos-positive
orexin cells in animals exposed to neonatal pain followed by later
life pain. Low and Fitzgerald (2012) also found this orexinergic
activity to be negatively correlated with rearing behavior. Together
these results suggest that the orexin system may be susceptible to
early life immune or emotional challenges, which promote neu-
roadaptations that manifest as dysregulated behavioral and neural
responses to painful stimuli in later life.
FOS-PROTEIN EXPRESSION IN STRESS RESPONSIVE BRAIN REGIONS
We identified an increased pattern of Fos-protein in brain
regions that are known to receive strong orexinergic input and
are involved in the neuroendocrine and behavioral response
to stress or pain modulation (Peyron et al., 1998; Marcus
et al., 2001; Vanegas and Schaible, 2004). The brain regions
we examined were the PVT, PVN, amygdala and PAG. LPS-
exposed animals displayed increased Fos-protein expression in
the PVT and PVN. The PVN and PVT both play an important
role in the neuroendocrine and autonomic responses to stress.
PVN corticotrophin-releasing factor cells constitute the apex of
the hypothalamic-pituitary-adrenal (HPA) axis and the PVT is
involved in regulating the HPA axis response to chronic stressors
(Bhatnagar and Dallman, 1998; Dayas et al., 2004; Kirouac et al.,
2005). Increased Fos immunoreactivity in the PVN and PVT is
therefore consistent with other studies demonstrating activation
of these stress response systems to a variety of physical stressors
including painful stimuli such as cold and formalin-induced pain
(Pacák and Palkovits, 2001).
Surprisingly, we found no changes in the numbers of Fos-
positive CeA nuclei between treatment groups. This result con-
trasts previous research demonstrating increased CeA activity
in response to physical stressors including persistent pain and
acute pain or stress (Dayas et al., 2001; Neugebauer et al., 2004).
Notably, orexin-immunoreactive fibers and orexin receptors are
also observed in other subregions of the amygdala including the
MeA (Peyron et al., 1998; Marcus et al., 2001). The MeA is typ-
ically sensitive to psychological stressors and has recently been
identified as a central site mediating repetitive self-grooming
behaviors, which has linked it to a range of neuropsychiatric
disorders (Dayas et al., 1999, 2001; LeDoux, 2000; Hong et al.,
2014). Interestingly, we observed a significant increase in Fos-
positive nuclei in the MeA of LPS-exposed animals, an effect
associated with elevated self-grooming responses to formalin. It is
possible that ascending spinoparabrachial projections may recruit
an orexin → MeA pathway resulting in affective-like behavioral
responses to formalin. However, the MeA also provides input
to DMH/PFA and may be recruited by ascending pain sensitive-
pathways. Further work will be required to understand the hier-
archical sequence for how these brain regions are recruited by
formalin.
Taken together, the behavioral data presented here confirmed
that animals exposed to an early life immune challenge exhib-
ited an enhanced inhibition of pain during the interphase. These
changes were associated with increased grooming behavior, which
was strongly correlated with numbers of Fos-positive orexin neu-
rons in the DMH/PFA. Our results are interesting given evidence
that patients suffering from chronic pain disorders tend to suf-
fer more from the affective disturbances of pain than frank pain
itself (Crombez et al., 1999). Further, processes modulated by
the orexin system eg. sleep, feeding, and motivation, are often
disturbed in people suffering chronic pain states (Dersh et al.,
2002). Thus, pharmacological or non-pharmacological interven-
tions that restore normal orexin system function may prove
beneficial in the treatment of chronic pain states.
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